GS71.DE vs. GILD
GS71.DE (GSK plc) and GILD (Gilead Sciences, Inc.) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past 10 years, GS71.DE returned 7.91%/yr vs 7.56%/yr for GILD. At a 0.22 correlation, their price movements are largely independent.
Performance
GS71.DE vs. GILD - Performance Comparison
Loading charts...
Different Trading Currencies
GS71.DE is traded in EUR, while GILD is traded in USD. To make them comparable, the GILD values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, GS71.DE achieves a 6.34% return, which is significantly lower than GILD's 7.90% return. Both investments have delivered pretty close results over the past 10 years, with GS71.DE having a 7.91% annualized return and GILD not far behind at 7.56%.
GS71.DE
- 1D
- 2.48%
- 1M
- 2.31%
- YTD
- 6.34%
- 6M
- 8.14%
- 1Y
- 26.83%
- 3Y*
- 16.08%
- 5Y*
- 11.83%
- 10Y*
- 7.91%
GILD
- 1D
- 0.79%
- 1M
- -3.37%
- YTD
- 7.90%
- 6M
- 8.99%
- 1Y
- 19.24%
- 3Y*
- 20.32%
- 5Y*
- 19.50%
- 10Y*
- 7.56%
GS71.DE vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GS71.DE GSK plc | 6.34% | 35.19% | 2.19% | 6.38% | -12.19% | 39.19% | -22.80% | 37.14% | 19.72% | -12.26% |
GILD Gilead Sciences, Inc. | 7.90% | 20.38% | 26.52% | -4.93% | 31.29% | 39.68% | -14.39% | 10.32% | -5.69% | -9.70% |
Correlation
The correlation between GS71.DE and GILD is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2007 | 0.22 |
Over the past year, GS71.DE and GILD have become more correlated (0.42) than their long-term average of 0.22, meaning their price movements have been converging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GS71.DE vs. GILD — Risk / Return Rank
GS71.DE
GILD
GS71.DE vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GSK plc (GS71.DE) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GS71.DE | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.40 | ||
| Sortino ratioReturn per unit of downside risk | +0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.14 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 1.17 | +0.47 |
| Martin ratioReturn relative to average drawdown | 3.70 | 2.88 | +0.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 0.73 | +0.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.80 | -0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.35 | 0.29 | +0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.49 | -0.36 |
Drawdowns
GS71.DE vs. GILD - Drawdown Comparison
The maximum GS71.DE drawdown since its inception was -66.28%, which is greater than GILD's maximum drawdown of -50.19%. Use the drawdown chart below to compare losses from any high point for GS71.DE and GILD.
Loading charts...
Drawdown Indicators
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.28% | -50.19% | -16.09% |
Max Drawdown (1Y)Largest decline over 1 year | -17.22% | -16.47% | -0.75% |
Max Drawdown (3Y)Largest decline over 3 years | -27.35% | -26.61% | -0.74% |
Max Drawdown (5Y)Largest decline over 5 years | -29.62% | -27.38% | -2.24% |
Max Drawdown (10Y)Largest decline over 10 years | -30.40% | -38.52% | +8.12% |
Current DrawdownCurrent decline from peak | -13.88% | -14.09% | +0.21% |
Average DrawdownAverage peak-to-trough decline | -26.09% | -20.71% | -5.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.63% | 6.70% | +0.93% |
Volatility
GS71.DE vs. GILD - Volatility Comparison
The current volatility for GSK plc (GS71.DE) is 5.88%, while Gilead Sciences, Inc. (GILD) has a volatility of 7.12%. This indicates that GS71.DE experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.88% | 7.12% | -1.24% |
Volatility (6M)Calculated over the trailing 6-month period | 17.62% | 18.29% | -0.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.83% | 26.32% | -1.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.07% | 24.43% | -1.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.48% | 26.09% | -3.61% |
Dividends
GS71.DE vs. GILD - Dividend Comparison
GS71.DE's dividend yield for the trailing twelve months is around 4.04%, more than GILD's 2.47% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.47% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
GS71.DE GSK plc | 4.04% | 4.12% | 5.07% | 4.43% | 6.31% | 6.79% | 8.51% | 6.12% | 7.74% | 8.78% | 9.54% | 8.46% |
Financials
GS71.DE vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between GSK plc and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GS71.DE and GILD have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GS71.DE and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer